8-K ·Filed Mar 12, 2026
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral
Monitor for public disclosure or press release from Dianthus Therapeutics regarding the nature of the agreement. Absence of financial details limits immediate trading implications.
Final — all horizons settled through T+60d ⚠ clustered
DNTH ▲ +0.24% at T+60d
NEUTRAL call ✓ call won +0.24% · α vs SPY -10.46% · entry $80.32 → $80.51
T+1d
-3.06%
call -3.06% · α -2.47%
$77.86
settled 7mo ago
T+5d
-0.40%
call -0.40% · α +0.58%
$80.00
settled 7mo ago
T+20d
+11.77%
call +11.77% · α +9.79%
$89.77
settled 6mo ago
T+60d
+0.24%
call +0.24% · α -10.46%
$80.51
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits), suggesting Dianthus Therapeutics may have entered a significant agreement, but no details are accessible to confirm nature or terms.
Key Facts
- Filing is Form 8-K with Items 1.01 and 9.01 reported.
- Item 1.01 indicates a material definitive agreement may have been entered into.
- Item 9.01 suggests financial statements or exhibits were filed, possibly related to the agreement.
- No document content available to verify agreement type, parties, or financial terms.
Financial Impact
Not specified
Risk Factors
- Material agreement could involve dilution, contingent payments, or strategic shift not currently quantifiable.
- Lack of accessible filing content increases information asymmetry risk.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
16 reports for DNTH
100% Hit rate best @ T+60▲ +41.40%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▲ +8.12% | ▲ +6.22% | $89.96 (+19.97%) |
Aug 10, 2026 7w ago | 144 | $108.49 $107.04 | ▼ −1.34% | ▼ −0.28% | $89.96 (−17.08%) |
Jun 29, 2026 13w ago | Press Release | $95.68 $103.87 | ▲ +8.56% | ▲ +8.84% | $89.96 (−5.98%) |
Jun 12, 2026 16w ago | 8-K | $82.07 $97.60 | ▲ +18.92% | ▲ +17.14% | $89.96 (+9.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $76.45 $100.03 | ▲ +30.84% | ▲ +28.95% | $89.96 (+17.67%) |
May 5, 2026 21w ago | 8-K | $90.42 $84.97 | ▼ −6.03% | ▼ −8.81% | $89.96 (−0.51%) |
Mar 12, 2026 29w ago | Press Release | $77.86 $90.00 | ▲ +15.59% | ▲ +12.00% | $89.96 (+15.54%) |
Showing 10 of 16
US Market Status
Market Open — Closes in 3h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access